The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy
Ventricular tachycardia (VT) and VF occur mainly in people with impaired cardiac function and/or ischaemic heart disease, and account for the majority of sudden cardiac deaths worldwide.1 Treatment with anti-arrhythmic drugs such as amiodarone may be at best neutral in terms of mortality and carries significant long-term risks.2,3 While ICDs significantly improve survival for patients with significantly impaired left ventricular ejection fraction (LVEF), the devices also carry risk
Source: Radcliffe Cardiology - Category: Cardiology Authors: mehul Source Type: research
More News: Amiodarone | Arrhythmia | Cardiology | Cardiomyopathy | Dilated Cardiomyopathy | Heart | Heart Disease | Ventricular Tachycardia